Development of an AAV-based microRNA gene therapy for treating spinocerebellar ataxia type 3

被引:0
|
作者
Evers, Melvin
Martier, Raygene
Stricker-Shaver, Janice
Hubener-Schmid, Jeannette
Keskin, Sonay
van Deventer, Sander
Huu Phuc Nguyen
Higgins, Joseph J.
Konstantinova, Pavlina
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:E531 / E531
页数:1
相关论文
共 50 条
  • [1] Development of an AAV-Based microRNA Gene Therapy for Myotonic Dystrophy Type 1
    Tomassy, Giulio Srubek
    Fan, Wei
    Magli, Alessandro
    Zhang, Tracy
    Boyle, Kristen
    Cao, James
    Jackson, Robert
    Sullivan, Jennifer
    Frederick, Amy M.
    O'Riordan, Catherine
    Goulet, Martin
    Mueller, Christian
    MOLECULAR THERAPY, 2023, 31 (04) : 500 - 500
  • [2] Development of an AAV-Based Gene Therapy for the Ocular Phenotype of Friedreich's Ataxia
    Tang, Heyu
    Xu, Emily M.
    Gupte, Siddhant S.
    Calabro, Kaitlyn R.
    Fajardo, Diego S.
    Peterson, James J.
    Friend, Hannah L.
    Boye, Sanford L.
    Boye, Shannon E.
    MOLECULAR THERAPY, 2024, 32 (04) : 761 - 761
  • [3] Development of an AAV-Based Gene Therapy for the Ocular Phenotype of Friedreich's Ataxia
    Gupte, Siddhant S.
    Calabro, Kaitlyn
    Fajardo, Diego
    Xu, Emily
    Kostamo, Zachary
    Zhang, Hangning
    Peterson, James
    Lutz, Cathleen
    Boye, Sanford
    Boye, Shannon
    MOLECULAR THERAPY, 2022, 30 (04) : 573 - 573
  • [4] Development of an AAV-Based microRNA Gene Therapy for Myotonic Dystrophy Type 1 (DM1)
    Kollu, Nageswara Rao
    Fan, Wei
    Sullivan, Jennifer
    Cao, Shuwen
    Cao, James
    Jackson, Robert
    Nass, Shelley
    Nambiar, Bindu
    Mattingly, Maryellen
    Woodcock, Denise
    Frederick, Amy
    Richards, Brenda
    Gans, Joseph
    Cummings, Sheila
    Bangari, Dinesh
    Assaf, Basel
    Tomassy, Giulio
    O'Riordan, Catherine
    Goulet, Martin
    Mueller, Christian
    MOLECULAR THERAPY, 2022, 30 (04) : 498 - 498
  • [5] Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
    Martier, Raygene
    Sogorb-Gonzalez, Marina
    Stricker-Shaver, Janice
    Huebener-Schmid, Jeannette
    Keskin, Sonay
    Klima, Jiri
    Toonen, Lodewijk J.
    Juhas, Stefan
    Juhasova, Jana
    Ellederova, Zdenka
    Motlik, Jan
    Haas, Eva
    van Deventer, Sander
    Konstantinova, Pavlina
    Huu Phuc Nguyen
    Evers, Melvin M.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 15 : 343 - 358
  • [6] Development of Novel AAV-Based Gene Therapy for Cardiac Disease
    Whittlesey, K.
    Brooks, G.
    Szymanski, P.
    Beliakoff, G.
    Nye, J.
    Croze, R.
    Schmitt, C.
    Bickta, J.
    Barglow, K.
    Kotterman, M.
    Francis, P.
    Schaffer, D.
    Kirn, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [7] Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye
    Rodrigues, Gerard A.
    Shalaev, Evgenyi
    Karami, Thomas K.
    Cunningham, James
    Slater, Nigel K. H.
    Rivers, Hongwen M.
    PHARMACEUTICAL RESEARCH, 2019, 36 (02)
  • [8] Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye
    Gerard A. Rodrigues
    Evgenyi Shalaev
    Thomas K. Karami
    James Cunningham
    Nigel K. H. Slater
    Hongwen M. Rivers
    Pharmaceutical Research, 2019, 36
  • [9] Preclinical Evaluation of an AAV-Based Gene Therapy Approach for the Treatment of Friedreich Ataxia Cardiomyopathy
    Martelli, Alain
    Assaf, Basel T.
    Gooch, Renea
    Ma, Tiffany
    Whiteley, Laurence O.
    Bulawa, Christine
    MOLECULAR THERAPY, 2019, 27 (04) : 51 - 51
  • [10] Allele-Specific AAV-Based Silencing of Mutant Ataxin-3 Alleviates Neuropathology and Motor Deficits in Spinocerebellar Ataxia Type 3
    Nobre, Rui Jorge
    Saraiva, Joana
    Santana, Magda
    Fusco, Clelia
    Paixao, Susana
    Miranda, Catarina
    Petrella, Lorena
    Sereno, Jose
    Castelhano, Joao
    Castelo-Branco, Miguel
    Sena-Esteves, Miguel
    de Almeida, Luis Pereira
    MOLECULAR THERAPY, 2020, 28 (04) : 404 - 405